Paratek Pharmaceuticals, Inc.

/Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics based upon tetracycline chemistry.

Symbol

Last Closing Price
$17.67

Shares
2,900,000

Effective Date
January 18, 2018

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange